Advertisement

Care of the Postoperative Patient with Liver Cancer in the Intensive Care Unit

  • Clint WestawayEmail author
  • Nizy Samuel
  • Jean Nicolas Vauthey
Reference work entry

Abstract

Cancers of the liver are increasing throughout the world. Cirrhosis, hepatitis B and C, nonalcoholic fatty liver disease, and metastases from cancers of the colon and the breast are some of the largest contributors to liver cancers. Many patients with chronic liver disease develop cirrhosis and then primary liver cancer. Cirrhosis may lead to increased fibrous tissue development and destruction of native liver cells. The exhaustion of the regenerative ability of the liver may contribute to the formation of hepatocellular carcinomas. Diagnosis of liver cancer is most frequently found through computed tomography (CT) and a rise in alpha-fetoprotein (AFP) levels. It may also be incidental to findings of another type of cancer, as in the metastatic form of cancer.

Keywords

Hepatocellular carcinoma Cirrhosis Chronic liver disease Metastatic liver disease Child-Turcotte-Pugh score MELD score Radiofrequency ablation (RFA) Microwave ablation Transcatheter arterial chemoembolization (TACE) Hepatectomy Portal vein embolization 

References

  1. 1.
    Abbas N, et al. Perioperative care of patients with liver cirrhosis: a review. Health Services Insights. 2017;10:1–12.  https://doi.org/10.1177/1178632917691270.
  2. 2.
    Abdeldayem H, et al. Preoperative evaluation and management of patients with liver disease. Recent Adv Liver Dis Surg. 2015;  https://doi.org/10.5772/60999. http://www.intechopen.com/books/recent-advances-in-liver-diseases-and-surgery
  3. 3.
    American Cancer Society. Breast cancer facts & figures 2017–2018. Atlanta: American Cancer Society; 2017.Google Scholar
  4. 4.
    American Cancer Society. What is liver cancer? Atlanta: American Cancer Society; 2016.Google Scholar
  5. 5.
    Breastcancer.org. Liver metastasis: local treatments. 2017. http://www.breastcancer.org/symptoms/types/recur_metast/treat_metast/options/local/liver. Accessed 26 Apr 2018.
  6. 6.
    Cancer.net. Neuroendocrine tumor: statistics. 2016. https://www.cancer.net/cancer-types/neuroendocrine-tumor/statistics. Accessed 23 Apr 2018.
  7. 7.
    Cicalese L, Geibel J. Hepatocellular carcinoma treatment & management. 2018. https://emedicine.medscape.com/article/197319-treatment#d8
  8. 8.
    Chakedis JMD, Carl R, Schmidt MD. Surgical treatment of metastatic colorectal Cancer. Surg Oncol Clin N Am. 2018;27:377–99.  https://doi.org/10.1016/j.soc.2017.11.010.CrossRefPubMedGoogle Scholar
  9. 9.
    Dalal A. Anesthesia for liver transplantation. Transplant Rev. 2016;30:51–60.  https://doi.org/10.1016/j.trre.2015.05.003.CrossRefGoogle Scholar
  10. 10.
    Egger M, et al. Anesthetic and operative considerations for laparoscopic liver resection. Surgery. 2017;161:1191–202.  https://doi.org/10.1016/j.surg.2016.07.011.CrossRefPubMedGoogle Scholar
  11. 11.
    Friedman LS. Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc. 2010;121:192–205.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Hartog A, Mills G. Anaesthesia for hepatic resection surgery. Br J Anaesth. 2009;9:1–5.  https://doi.org/10.1093/bjaceaccp/mkn050.CrossRefGoogle Scholar
  13. 13.
    Kashimutt S, Kotze A. Anaesthesia for liver transplantation. Br J Anaesth. 2016;17:35–40.  https://doi.org/10.1093/bjaed/mkw031.CrossRefGoogle Scholar
  14. 14.
    Kishi Y, et al. Three hundred and one consecutive extended right hepatectomies. Ann Surg. 2009;250:540–8.  https://doi.org/10.1097/SLA.0b013e3181b674df.CrossRefPubMedGoogle Scholar
  15. 15.
    Konstantinidis IT. Primary liver sarcomas in the modern era: resection or transplantation? J Surg Oncol. 2018;117:1–6.  https://doi.org/10.1002/jso.24979.
  16. 16.
    Labgaa I, et al. Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: a multicentric study. Am J Surg. 2018;215:125–30.  https://doi.org/10.1016/j.amjsurg.2017.09.030.CrossRefPubMedGoogle Scholar
  17. 17.
    Lee KF, et al. Long-term outcomes of microwave verse radiofrequency ablation for hepatocellular carcinoma by surgical approach: a retrospective comparative study. Asian J Surg. 2017;40:301–8.  https://doi.org/10.1016/j.asjsur.2016.01.001.CrossRefPubMedGoogle Scholar
  18. 18.
    Lin Y-H, et al. Surgical experience of adult primary hepatic sarcomas. World J Surg Oncol. 2015;13:87.  https://doi.org/10.1186/s12957-015-0489-6.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Matias M, et al. Prognostic factors after liver resection for colorectal liver metastases. Acta Med Port. 2015;28(3):357–69.CrossRefGoogle Scholar
  20. 20.
    Mittal S, El-Serag HB. Epidemiology of HCC: consider the population. J Clin Gastroenterol. 2013;47(0):S2–6.  https://doi.org/10.1097/MCG.0b013e3182872f29.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    National Cancer Institute. Cancer stat facts: female breast cancer, based on SEER cancer statistics review. https://seer.cancer.gov/statfacts/html/breast.html. Accessed 1 Apr 2019.
  22. 22.
    Ogata S, et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg. 2006;93:1091–8.CrossRefGoogle Scholar
  23. 23.
    Omichi K, et al. Portal vein embolization reduces postoperative hepatic insufficiency associated with postchemotherapy hepatic atrophy. J Gastrointest Surg. 2018;22(1):60–7.  https://doi.org/10.1007/s11605-017-3467-1.
  24. 24.
    Page A, Kooby D. Perioperative management of hepatic resection. J Gastrointest Oncol. 2012;3:19–27.  https://doi.org/10.3978/j.issn.2078-6891.2012.005.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Palavecino M, et al. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: perioperative outcome and survival. J Surg. 2009;145:399–405.  https://doi.org/10.1016/j.surg.2008.10.009.CrossRefGoogle Scholar
  26. 26.
    Patel T. Surgery in the patient with liver disease. Mayo Clin Proc. 1999;74:593–9.CrossRefGoogle Scholar
  27. 27.
    Rahbari NN, et al. Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial. Ann Surg. 2011;253:1102–10.CrossRefGoogle Scholar
  28. 28.
    Ryder SD. British Society of Gastroenterology (2003). Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut, 2003;52 Suppl 3(Suppl 3), iii1–iii8.  https://doi.org/10.1136/gut.52.suppl_3.iii1.
  29. 29.
    Sanyal AJ, et al. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist. 2010;15:14–22.  https://doi.org/10.1634/theoncologist.2010-S4-14.CrossRefPubMedGoogle Scholar
  30. 30.
    Sheth KR, Clary BM. Management of hepatic metastases from colorectal cancer. Clin Colon Rectal Surg. 2005;18(3):215–23.  https://doi.org/10.1055/s-2005-916282.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Tympa A, et al. Anesthetic considerations in hepatectomies under hepatic vascular control. HPB Surg. 2012;2012:1–12.  https://doi.org/10.1155/2012/720754.CrossRefGoogle Scholar
  32. 32.
    University of California San Francisco. Microwave ablation. https://liversource.surgery.ucsf.edu/conditions%2D%2Dprocedures/microwave-ablation.aspx. Accessed 20 Apr 2018.
  33. 33.
    Vauthey JN. The AHPBA 2006 consensus conference: focus on improving resectability in patients with hepatic colorectal metastases. Appeared on Medscape Tuesday March 26, 2019. https://www.medscape.org/viewarticle/524135. Accessed 2 Apr 2019.
  34. 34.
    UpToDate. Model for End-stage Liver Disease (MELD). Wolters Kluwer; 2018. https://www.uptodate.com/contents/model-for-end-stage-liver-disease-meld#H16431884. Accessed 20 Apr 2018.
  35. 35.
    Wells MM, Schiano T. Preoperative and postoperative care of the liver patient. In: Saeian K., Shaker R. (eds) Liver Disorders. Springer, Cham. Liver Disord. 2017;99–18.  https://doi.org/10.1007/978-3-319-30103-7_8.
  36. 36.
    Wijdicks E. Hepatic encephalopathy. N Engl J Med. 2016;375:1660–70.  https://doi.org/10.1056/NEJMra1600561.CrossRefPubMedGoogle Scholar
  37. 37.
    Zhao J, et al. Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases. Br J Surg. 2017;104(8):990–1002.  https://doi.org/10.1002/bjs.10572.
  38. 38.
    Zhang X-f, et al. Timing of disease occurrence and hepatic resection on long-term outcome of patients with neuroendocrine liver metastasis. J Surg Oncol. 2018;117:171–81.  https://doi.org/10.1002/jso.24832.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Clint Westaway
    • 1
    Email author
  • Nizy Samuel
    • 1
  • Jean Nicolas Vauthey
    • 2
  1. 1.Department of Anesthesiology, Critical Care and Pain MedicineThe University of Texas MD Anderson Cancer CenterHoustonUSA
  2. 2.Hepato-Pancreato-Biliary Section, Department of Department of Surgical OncologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Section editors and affiliations

  • Garry Brydges
    • 1
  1. 1.Department of Anesthesiology Division of Anesthesia, Critical Care and Pain MedicineThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations